Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Teal Valley T.TV


Primary Symbol: P.TEAL

Healthcare Cannabis
Teal is a Canadian, pharmaceutical & NHP manufacturer selling to Canada’s national, chain drug stores, presently expanding its portfolio to include cannabinoid-based products utilizing proprietary formulations & extractions for both the global Rx & recreational markets.


P.TEAL - Post by User

Teal Valley > Eight Capital: Sell rating and C$1.00 target for Trevali
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(128)
•••
Comment by Redfoxyon May 17, 2022 9:32pm
122 Views
Post# 34691113

RE:RE:RE:Eight Capital: Sell rating and C$1.00 target for Trevali

RE:RE:RE:Eight Capital: Sell rating and C$1.00 target for TrevaliKram - excellent post.

Santa is making toys on the North Pole and is making a list as well.  Oh yes, tooth fairy is real to.

No tought went into the recommendation and doubt that the analyst even knows who or what TV is all about.

Junk reporting and I hit the BS buttoon!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities